Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer
Authors
Keywords
Gene expression, Notch signaling, Homeostasis, Pathogenesis, Principal component analysis, RNA extraction, Cancer treatment, Hepatic resection
Journal
PLoS One
Volume 13, Issue 6, Pages e0198099
Publisher
Public Library of Science (PLoS)
Online
2018-06-08
DOI
10.1371/journal.pone.0198099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
- (2018) Patrice N. Mimche et al. Scientific Reports
- Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?
- (2017) Silvia Santamaria et al. Frontiers in Immunology
- Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression
- (2016) Zhe Shen et al. AMERICAN JOURNAL OF PATHOLOGY
- Endothelial notch signaling is essential to prevent hepatic vascular malformations in mice
- (2016) Henar Cuervo et al. HEPATOLOGY
- Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry
- (2016) Jametta S. Magwood-Golston et al. LEUKEMIA RESEARCH
- Notch signalling in context
- (2016) Sarah J. Bray NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
- (2015) M Mohty et al. BONE MARROW TRANSPLANTATION
- A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
- (2015) E. G. Chiorean et al. CLINICAL CANCER RESEARCH
- Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation
- (2015) J. A. Couch et al. CLINICAL CANCER RESEARCH
- The Endothelial Transcription Factor ERG Promotes Vascular Stability and Growth through Wnt/β-Catenin Signaling
- (2015) Graeme M. Birdsey et al. DEVELOPMENTAL CELL
- The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome
- (2015) Chiara Marzano et al. HEPATOLOGY
- Hepatotoxicity of Pyrrolizidine Alkaloids
- (2015) Manuela G Neuman et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- p21WAF1 Is Required for Interleukin-16-Induced Migration and Invasion of Vascular Smooth Muscle Cells via the p38MAPK/Sp-1/MMP-9 Pathway
- (2015) Sung Lyea Park et al. PLoS One
- Development of a safety biomarker signature to detect hepatic sinusoidal dilation associated with an anti-DLL4 biotherapeutic
- (2014) Jacqueline M. Tarrant et al. BIOMARKERS
- A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors
- (2014) D. C. Smith et al. CLINICAL CANCER RESEARCH
- Therapeutic modulation of Notch signalling — are we there yet?
- (2014) Emma R. Andersson et al. NATURE REVIEWS DRUG DISCOVERY
- Downregulation of the Endothelial Genes Notch1 and EphrinB2 in Patients with Nodular Regenerative Hyperplasia
- (2013) Sonja Rothweiler et al. LIVER INTERNATIONAL
- Interleukin-16 Promotes Cardiac Fibrosis and Myocardial Stiffening in Heart Failure with Preserved Ejection Fraction
- (2013) Shunsuke Tamaki et al. PLoS One
- Disruption of Notch1 Induces Vascular Remodeling, Intussusceptive Angiogenesis, and Angiosarcomas in Livers of Mice
- (2012) Michael T. Dill et al. GASTROENTEROLOGY
- Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases
- (2012) Celien P H Vreuls et al. HISTOPATHOLOGY
- Management of hepatic vascular diseases
- (2012) Aurélie Plessier et al. JOURNAL OF HEPATOLOGY
- Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases
- (2012) Anne E.M. van der Pool et al. JOURNAL OF SURGICAL ONCOLOGY
- MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis In Vivo
- (2012) D. W. Jenkins et al. MOLECULAR CANCER THERAPEUTICS
- Notch4 Normalization Reduces Blood Vessel Size in Arteriovenous Malformations
- (2012) P. A. Murphy et al. Science Translational Medicine
- Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation
- (2011) Julie Agostini et al. JOURNAL OF HEPATOLOGY
- Gene Expression Profiling Provides Insights into Pathways of Oxaliplatin-Related Sinusoidal Obstruction Syndrome in Humans
- (2011) L. Rubbia-Brandt et al. MOLECULAR CANCER THERAPEUTICS
- Anti-DLL4 Inhibits Growth and Reduces Tumor-Initiating Cell Frequency in Colorectal Tumors with Oncogenic KRAS Mutations
- (2010) M. Fischer et al. CANCER RESEARCH
- Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis
- (2010) Laura Rubbia-Brandt et al. HISTOPATHOLOGY
- Chronic DLL4 blockade induces vascular neoplasms
- (2010) Minhong Yan et al. NATURE
- Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade
- (2009) S. Yamanda et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now